
Raising Awareness on World Blood Cancer Day
On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
After living cancer-free for 15 years, Rob faced two devastating relapses of stage 4 lymphoma. The thought of enduring another six months of chemotherapy was overwhelming — until he was offered a place on the ZUMA-22 clinical trial, exploring the use of CAR-T cell therapy for relapsed lymphoma patients.
Amelie was three when she was first diagnosed with leukaemia. Ten years and four relapses later, she’s finally ready for a new beginning.
Jonathan’s experience with the TAP-funded FEDORA Clinical Trial didn’t just improve his health—it gave him a second chance at life, highlighting the life-changing potential of clinical trials for patients with limited treatment options.
Diagnosed with a rare and aggressive blood cancer affecting the brain, Caroline’s hope came through a groundbreaking clinical trial.
After a shock of Acute Lymphoblastic Leukaemia in late 2023, Neil Morris underwent intensive treatment and a life-saving stem cell transplant—made possible by a selfless donor from Germany, giving him a second chance at life.
At 26, Steve, a musician from Birmingham, was diagnosed with T-Cell Acute Lymphoblastic Leukaemia and joined the ALL-Together-1 clinical trial.